ResearcherNorthern Jiangsu People's HospitalActive in the last 2 years
Changren Zhu
Matched on OpenAlex author ID A5005324241. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2024: 1 paper · 2025: 1 paper
Papers 2
- Correction: PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. Co-author DOI 10.1007/s10616-025-00760-4↗
- PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. Co-author DOI 10.1007/s10616-024-00626-1↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qing Xu · 2 shared papers, 2024–2025 · strength 0.56
- Paper Correction: PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT … DOI 10.1007/s10616-025-00760-4↗
- Paper PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. DOI 10.1007/s10616-024-00626-1↗
- Jun Zheng · 2 shared papers, 2024–2025 · strength 0.56
- Paper Correction: PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT … DOI 10.1007/s10616-025-00760-4↗
- Paper PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. DOI 10.1007/s10616-024-00626-1↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.